FORMULATION AND IN-VITRO CHARACTERIZATION OF LORNOXICAM TRANSDERMAL MATRIX PATCH
DOI:
https://doi.org/10.7439/ijap.v5i2.3080Abstract
Transdermal therapeutic systems are defined as self-contained, discrete dosage forms which, when applied to intact skin, deliver drug(s), through skin, at a controlled rate to systemic circulation. In the present study transdermal patches of Lornoxicam were prepared using hydrophilic polymer and hydrophobic polymer. Transdermal drug delivery system has the potential advantages of avoiding hepatic first pass metabolism, maintaining constant blood levels for a longer period of time, resulting in a reduction of dosing frequency, improved bioavailability, and decreased gastrointestinal irritation that occur due to local contact with gastric mucosa and improved patient compliance. Lornoxicam is a newer NSAID of the oxicam class for the treatment of anti-inflammatory properties in a range of painful and inflammatory conditions, including Rheumatoid arthritis and postoperative pain. Lornoxicam Patch was prepared by the solvent casting method using HPMC various grade and Eudragit RS 100 as a polymer, PEG-400 and Tween 80 uses as plasticizer, Methanol and Dichloromethane used as solvent. LXTMP1 showed desired % Drug Content, Thickness, Folding Endurance, Flatness, Diffusion Study, Sensitivity Study on animal and Kinetic Model Study and better than other seven batches so, it is selected optimized batch.Downloads
Download data is not yet available.
Downloads
Published
2016-03-20
Issue
Section
Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
1.
FORMULATION AND IN-VITRO CHARACTERIZATION OF LORNOXICAM TRANSDERMAL MATRIX PATCH. Int J Adv Pharm [Internet]. 2016 Mar. 20 [cited 2024 Sep. 8];5(2):30-8. Available from: https://ssjournals.co.in/index.php/ijap/article/view/3080